AI English summary of an SEC filing — figures as filed
The company said the Board of Directors elected Joseph J. Wolk as an independent director on September 30, 2025, with the appointment effective 30 2025.
Key points
AI summaryThe company said the Board of Directors elected Joseph J. Wolk as an independent director on September 30, 2025, with the appointment effective 30 2025.
The company said Wolk was appointed to the Audit Committee and Finance Committee, and that non-employee director compensation is described in the Non-Employee Director Compensation Summary filed as Exhibit 10.26 to the Company's 2024 Annual Report on Form 10-K.
Prudential Financial said Wolk is currently executive vice president and chief financial officer at Johnson & Johnson, and that since his appointment as chief financial officer in 2018 he has led the company's long-term financial strategy and capital allocation, including the separation of Johnson & Johnson's consumer health business.
The company said Wolk joined Johnson & Johnson in 1998 and previously held various accounting roles at AMETEK, Inc., and that director Sandra Pianalto noted his deep expertise in global finance would be an asset.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Joseph J. Wolk Elected as Independent Director
The company said the Board of Directors elected Joseph J. Wolk as an independent director on September 30, 2025, with the appointment effective 30 2025.
Source · Based on the filing body and exhibits
Appointment to Audit and Finance Committees and Director Compensation
The company said Wolk was appointed to the Audit Committee and Finance Committee, and that non-employee director compensation is described in the Non-Employee Director Compensation Summary filed as Exhibit 10.26 to the Company's 2024 Annual Report on Form 10-K.
Source · Based on the filing body and exhibits
Wolk's Career at Johnson & Johnson
Prudential Financial said Wolk is currently executive vice president and chief financial officer at Johnson & Johnson, and that since his appointment as chief financial officer in 2018 he has led the company's long-term financial strategy and capital allocation, including the separation of Johnson & Johnson's consumer health business.
Source · Based on the filing body and exhibits
Wolk's Background and Director Pianalto's Remarks
The company said Wolk joined Johnson & Johnson in 1998 and previously held various accounting roles at AMETEK, Inc., and that director Sandra Pianalto noted his deep expertise in global finance would be an asset.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…